Science News
from research organizations

Aggressive breast cancers may be sensitive to drugs clogging their waste disposal

Date:
August 12, 2013
Source:
Boston Children's Hospital
Summary:
A new report suggests that "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins.
Share:
       
FULL STORY

In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins.

These cancers, which lack the three major therapeutic markers for breast cancer -- the estrogen, progesterone and HER2 receptors -- are very aggressive and difficult to treat. They mostly affect younger women and have the worst prognosis of all breast cancers.

By selectively turning genes off throughout the genomes of triple-negative tumor cells in vitro, Lieberman's team found that these cells absolutely require active proteasomes in order to live. When turned off, the cells die.

These data suggest that triple-negative breast cancers may respond to treatment with drugs similar to bortezomib (Velcade®), a proteasome inhibitor that revolutionized the care of patients with the blood cancer multiple myeloma.


Story Source:

The above story is based on materials provided by Boston Children's Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Pei-Yin Hsu, Hang-Kai Hsu, Xun Lan, Liran Juan, Pearlly S. Yan, Jadwiga Labanowska, Nyla Heerema, Tzu-Hung Hsiao, Yu-Chiao Chiu, Yidong Chen, Yunlong Liu, Lang Li, Rong Li, Ian M. Thompson, Kenneth P. Nephew, Zelton D. Sharp, Nameer B. Kirma, Victor X. Jin, Tim H.-M. Huang. Amplification of Distant Estrogen Response Elements Deregulates Target Genes Associated with Tamoxifen Resistance in Breast Cancer. Cancer Cell, 2013; 24 (2): 197 DOI: 10.1016/j.ccr.2013.07.007

Cite This Page:

Boston Children's Hospital. "Aggressive breast cancers may be sensitive to drugs clogging their waste disposal." ScienceDaily. ScienceDaily, 12 August 2013. <www.sciencedaily.com/releases/2013/08/130812154414.htm>.
Boston Children's Hospital. (2013, August 12). Aggressive breast cancers may be sensitive to drugs clogging their waste disposal. ScienceDaily. Retrieved May 25, 2015 from www.sciencedaily.com/releases/2013/08/130812154414.htm
Boston Children's Hospital. "Aggressive breast cancers may be sensitive to drugs clogging their waste disposal." ScienceDaily. www.sciencedaily.com/releases/2013/08/130812154414.htm (accessed May 25, 2015).

Share This Page: